Unlabelled: The prevalence of locally advanced breast cancer is increasing yearly, so biomarkers are needed to assist in its management, one of which is tumour necrosis factor-alpha (TNF-α).
Objective: Analysing TNF-α levels as a predictor factor on clinical response anthracycline-based neoadjuvant chemotherapy.
Methods: This study design used observational analysis.